Apple kept Split View side-by-side multitasking in iPadOS 26 — despite what you might have read online. And setting it up is as easy as a couple of flicks of your finger. Here’s how to keep using ...

The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...

The FDA approved darolutamide for mHSPC on June 3, [2025], so we now have this in our armamentarium, along with all the other ...

Experts hail the ‘very exciting” discovery that the oft-observed protection against triple-negative breast cancer afforded by breastfeeding may be due to resident T cells left behind in the breast.

Pregnancy and breastfeeding leave behind long-lived CD8+ T cells that can persist for decades, providing lasting immune surveillance in breast tissue.

On 7, Professor Sheng Jindong from Tianjin Cancer Hospital presented oral results on the efficacy and safety of sacituzumab tirumotecan (sac-TMT) monotherapy for locally advanced or metastatic ...

Orion Oyj (ORINY) reports robust growth in operating profit and innovative medicines, despite facing delivery delays and increased fixed costs.

Learn more about whether Microchip Technology Incorporated or MKS Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

IMU Biosciences' precision medicine platform maps the immune system to improve diagnosis, treatment, and healthcare outcomes.

Learn more about whether Intel Corporation or MKS Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The markets in 2025 have kept investors on edge ? interest-rate swings, AI-driven rallies, and unexpected pullbacks have reshaped portfolios across every asset class. But as 2026 approaches, many ...

The nights of Oct. 20 and 21 mark the peak of the Orionid Meteor shower (as in, stay up late Monday and Tuesday nights). This annual event occurs when the Earth revolves into a stream of material left ...